084440 — U Bion Co Balance Sheet
0.000.00%
- KR₩26bn
- KR₩26bn
- KR₩33bn
- 62
- 30
- 54
- 47
Annual balance sheet for U Bion Co, fiscal year end - September 30th, KRW millions except per share, conversion factor applied.
R2020 September 30th | R2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | — | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,101 | 1,194 | 1,080 | 2,396 | 3,142 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5,071 | 4,703 | 6,682 | 8,784 | 10,502 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 8,861 | 7,136 | 10,820 | 15,066 | 15,074 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,696 | 1,771 | 1,493 | 1,448 | 1,509 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 16,331 | 14,172 | 18,828 | 22,830 | 23,149 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 16,502 | 10,852 | 13,998 | 13,348 | 16,273 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 18,497 | 11,947 | 14,450 | 13,689 | 16,909 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | -2,166 | 2,225 | 4,378 | 9,141 | 6,240 |
Total Liabilities & Shareholders' Equity | 16,331 | 14,172 | 18,828 | 22,830 | 23,149 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |